About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
RET-Positive Metastatic NSCLC
RET-Positive Metastatic NSCLC
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
L
Lecture Summary - Selpercatinib in RET Fusion-Positive mNSCLC: Achievements and Gray Areas
By
Lorenzo Belluomini
3 Videos
750 views
August 8, 2022
0 Comments
Login to view comments.
Click here to Login
RET-Positive Metastatic NSCLC
23:53
Priyanka Iyer
Biomarkers in Thyroid Cancer: Endocrinologist's Perspective
14:05
Yale School of Medicine
Molecular Markers in Thyroid Cancer from the Endocrinologist's …
Feat.
E. Holt
14:11
Lorenzo Belluomini
Selpercatinib in RET Fusion-Positive mNSCLC: Achievements and Gray A…
01:01
Lorenzo Belluomini
Lecture Summary - Selpercatinib in RET Fusion-Positive mNSCLC: Achie…
19:19
Nicola Normanno
Rebiopsy and cfDNA in a Complex and Changing NSCLC Landscape
15:19
GRACE
The Role of Chemotherapy in Driver Positive NSCLC
Feat.
J. Weiss
13:32
CancerGRACE
Targeted Therapies in Oligo-Metastatic NSCLC
Feat.
T. Leal
05:02
ASCO 2022 Conference Coverage
ASCO 2022 on IO and Chemo-IO for NSCLC With Novel Actionable Oncogen…
Feat.
L. Mazzeo,
M. Occhipinti
07:37
ASCO 2022 Conference Coverage
ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo in 1L mNSCLC: AE Ma…
Feat.
B. Chul Cho
01:28
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo i…
Feat.
B. Chul Cho
06:45
WCLC 2022 Conference Coverage
WCLC 2022 on the Phase 3 SANOVO Study: Savolitinib or Placebo in Com…
Feat.
Q. Zhou
07:18
WCLC 2022 Conference Coverage
WCLC 2022 on the NADIM II Trial: Pre-Treatment ctDNA Levels Signific…
Feat.
A. Romero
04:11
WCLC 2022 Conference Coverage
WCLC 2022 on 1L Chemotherapy vs. Chemoimmunotherapy in Stage IV LCNE…
Feat.
L. Meng
35
WCLC 2022 Conference Coverage
Lecture Summary - WCLC 2022 on 1L Chemotherapy vs. Chemoimmunotherap…
Feat.
L. Meng
09:13
WCLC 2022 Conference Coverage
WCLC 2022 on KEYNOTE B36: A Pilot Study of 1L Tumor Treating Fields …
Feat.
R. Kotecha
01:22
WCLC 2022 Conference Coverage
Lecture Summary - WCLC 2022 on KEYNOTE B36: A Pilot Study of 1L Tumo…
Feat.
R. Kotecha
15:13
Feredun Azari
Intraoperative Molecular Imaging Guided Resection of CEACAM5+ Lung T…
01:13
Feredun Azari
Lecture Summary - Intraoperative Molecular Imaging Guided Resection …
12:35
WCLC 2022 Conference Coverage
WCLC 2022 on Socio-Economic Inequalities in NSCLC Treatment During t…
Feat.
R. Norris
56
WCLC 2022 Conference Coverage
Lecture Summary - WCLC 2022 on Socio-Economic Inequalities in NSCLC …
Feat.
R. Norris
05:34
WCLC 2022 Conference Coverage
WCLC 2022 on the Phase II DOLPHIN Study: Durvalumab + Concurrent RT …
Feat.
M. Tachihara
08:26
ESMO 2022 Conference Coverage
ESMO 2022 on the Results of the Randomized DICIPLE Phase 3 Trial: Ni…
Feat.
G. Zalcman
03:24
ESMO 2022 Conference Coverage
Lecture Summary - ESMO 2022 on the Results of the Randomized DICIPLE…
Feat.
G. Zalcman
